Clinical Study

Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves’ Hyperthyroidism: A Randomized Controlled Study

Table 3

Cumulative rate of achieving euthyroidism and occurrence of hypothyroidism during treatment with 15 mg/day OD-MMI and 15 mg/day DD-MMI.

Week 0Week 2Week 4Week 8Week 12
Cases (%)Cases (%)Cases (%)Cases (%)Cases (%)

Euthyroidism
OD-MMI ()0 (0%)1 (4.8%)6 (28.6%)15 (71.4%)18 (85.7%)
DD-MMI ()0 (0%)1 (4.3%)8 (34.8%)19 (82.6%)20 (87.0%)
Hypothyroidism
OD-MMI ()0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
DD-MMI ()003 (13.0%)1 (4.3%)0 (0%)

15 mg/day OD-MMI, 15 mg/day of methimazole administered once daily; 15 mg/day DD-MMI, 15 mg/day of methimazole administered dividedly in 5 mg three times a day. No significant difference in rate of achieving euthyroidism between the two treatment regimens. 15 mg/day DD-MMI induced hypothyroidism significantly more than 15 mg/day OD-MMI ().